AHCO Earnings & Financial Statements
AdaptHealth Corp.
$6.39
+$0.14(+2.24%)
46
Overall
60
Value
36
Tech
44
Quality
Market Cap
$871.24M
Volume
1.61M
52W Range
$5.21 - $13.43
Target Price
$8.86
AHCO earnings and financial statements: AdaptHealth Corp.'s income statement, balance sheet and cash flow statement, annual and quarterly.
AHCO Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $3.24B | $3.26B | $3.20B | - | $10.60M |
| Cost of revenue | $2.64B | $2.58B | $2.58B | $2.55B | $2.01B |
| Operating income | $90.87M | $263.73M | -$598.40M | $190.41M | $225.60M |
| EBITDA | $524.68M | $677.67M | -$167.69M | $595.96M | $544.21M |
| Net income | -$70.79M | $90.42M | -$678.89M | $69.32M | $156.18M |
| EPS (diluted) | $-0.52 | $0.61 | $-5.31 | $0.33 | $0.67 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $4.32B | $4.49B | $4.51B | $5.22B | $5.25B |
| Total liabilities | $2.79B | $2.91B | $3.04B | $3.06B | $3.18B |
| Shareholders’ equity | $1.52B | $1.57B | $1.46B | $2.15B | $2.06B |
| Cash and equivalents | - | - | - | $46.27M | $149.61M |
| Long-term debt | $1.83B | $2.07B | $2.20B | $2.26B | $2.30B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $601.77M | $541.84M | $480.67M | $373.87M | $275.68M |
| Capital expenditure | -$382.39M | -$300.74M | -$337.46M | -$391.42M | -$203.31M |
| Free cash flow | $219.38M | $235.78M | $143.20M | -$17.56M | $72.37M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AHCO | $6.39 | +2.2% | 1.61M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |